Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy

類似資料

• Phase 2 Study of Carboplatin, Docetaxel, and Bevacizumab as Frontline Treatment for Advanced Nonsmall-Cell Lung Cancer
  著者:: William, William N., 等
  出版事項: (2010)
• Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC – a phase II trial
  著者:: Babiak, A, 等
  出版事項: (2007)
• Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non-Small-Cell Lung Cancer
  著者:: Ramalingam, Suresh S., 等
  出版事項: (2013)
• A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer.
  著者:: Iaffaioli, R. V., 等
  出版事項: (1995)
• Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas
  著者:: William, William N., 等
  出版事項: (2018)